SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases
SWE Predict
Evaluation of SWE as a Predictive Tool for Progression of Chronic Liver Diseases
1 other identifier
observational
2,148
0 countries
N/A
Brief Summary
This study is a multicenter individual patient-based meta-analysis that will assess the performances of liver stiffness measurements performed with supersonic shear imaging shearwave elastography (SSI-SWE) in patients with liver fibrosis to predict progression of chronic liver disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2007
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 26, 2007
CompletedFirst Submitted
Initial submission to the registry
December 20, 2017
CompletedFirst Posted
Study publicly available on registry
January 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2019
CompletedJuly 27, 2020
July 1, 2020
10.5 years
December 20, 2017
July 23, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Liver disease progression rate
Clinical signs of liver decompensation
Minimum of 28 days follow-up
Mortality rate
Patient's death
Minimum of 28 days follow-up
Interventions
liver stiffness measurements by shear wave-based elastography
Eligibility Criteria
Patients with suspected or confirmed chronic liver disease of viral and/or steatotic origin, requiring a percutaneous liver biopsy, and who had received a liver ultrasound exam at baseline for a suspected chronic fibrotic liver disease.
You may qualify if:
- Patients who had received a liver ultrasound exam at baseline for a suspected chronic fibrotic liver disease of viral and/or steatotic origin,
- Patients who had reached the age of majority in their countries, at baseline,
- Patients with a baseline liver biopsy for histological evaluation of liver fibrosis with a length ≥ 15 mm paraffin sections (except if cirrhosis),
- Patients for whom a minimum length of clinical follow-up from baseline of 1 year had been recorded
You may not qualify if:
- Cause of chronic liver disease other than viral, ALD or NAFLD ( hemochromatosis, autoimmune hepatitis, biliary tract disease intrahepatic...)
- Any systemic, viral hepatitis and HIV co-infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SuperSonic Imaginelead
- University of Bonncollaborator
Related Publications (2)
Herrmann E, de Ledinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J, Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P, Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J, Deffieux T, Friedrich-Rust M. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. Hepatology. 2018 Jan;67(1):260-272. doi: 10.1002/hep.29179. Epub 2017 Nov 15.
PMID: 28370257BACKGROUNDGu W, de Ledinghen V, Aube C, Krag A, Strassburg C, Castera L, Dumortier J, Friedrich-Rust M, Pol S, Grgurevic I, Zeleke Y, Praktiknjo M, Schierwagen R, Klein S, Francque S, Gottfriedova H, Sporea I, Schindler P, Rennebaum F, Brol MJ, Schulz M, Uschner FE, Fischer J, Margini C, Wang W, Delamarre A, Best J, Canbay A, Bauer DJM, Simbrunner B, Semmler G, Reiberger T, Boursier J, Rasmussen DN, Vilgrain V, Guibal A, Zeuzem S, Vassord C, Vonghia L, Senkerikova R, Popescu A, Berzigotti A, Laleman W, Thiele M, Jansen C, Trebicka J. Hepatocellular Cancer Surveillance in Patients with Advanced Chronic Liver Disease. NEJM Evid. 2024 Nov;3(11):EVIDoa2400062. doi: 10.1056/EVIDoa2400062. Epub 2024 Oct 22.
PMID: 39437136DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2017
First Posted
January 3, 2018
Study Start
July 26, 2007
Primary Completion
January 9, 2018
Study Completion
November 28, 2019
Last Updated
July 27, 2020
Record last verified: 2020-07